Michael Schmidt

Stock Analyst at Guggenheim

(0.95)
# 2052
Out of 5,333 analysts
143
Total ratings
42.42%
Success rate
-8.25%
Average return
51 Stocks
Name Action PT Current % Upside Ratings Updated
ONC BeiGene
Maintains: Strong Buy
348 350
236.21 48.17% 3 May 8, 2025
RVMD Revolution Medicines
Maintains: Buy
87 80
42 90.48% 3 May 8, 2025
RLAY Relay Therapeutics
Maintains: Buy
30 10
3.02 231.13% 1 May 7, 2025
SNDX Syndax Pharmaceuticals
Reiterates: Buy
32 32
11.01 190.64% 3 May 6, 2025
ARVN Arvinas
Maintains: Buy
32 16
6.8 135.29% 5 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
77 47
46.2 1.73% 2 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 3 Apr 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 8
3.35 138.81% 2 Apr 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 7
1.28 446.88% 4 Mar 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
109 109
42.8 154.67% 5 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
3 2
0.3 483.33% 3 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
13 14
6.95 101.44% 3 Mar 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 25
7.74 223% 2 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
92 92
59.73 54.03% 5 Mar 18, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 1 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
45
19.81 127.16% 1 Mar 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 5 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
42 42
36.51 15.04% 8 Feb 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 1 Jan 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 2 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
3.38 491.72% 1 Dec 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 8
1.26 534.92% 3 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Oct 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Mar 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
7
0.34 1958.82% 2 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
350 345
n/a n/a 4 Feb 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jan 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 31
n/a n/a 1 Dec 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 34
8.79 286.8% 4 Nov 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
104 60
n/a n/a 10 Jul 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
20
0.48 4066.67% 3 Jun 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
170
n/a n/a 3 Feb 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Sep 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
1.39 1698.56% 1 Aug 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
30
4.21 612.59% 1 Jul 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
26
6.98 272.49% 1 May 18, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
35 39
n/a n/a 1 Apr 23, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Dec 27, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 48
n/a n/a 2 Dec 11, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Mar 5, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
80
28.07 185% 4 Feb 15, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 4 Jan 17, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
30
n/a n/a 2 Sep 25, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Outperform
24
n/a n/a 3 Sep 13, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
56 87
n/a n/a 4 Jan 23, 2018